Guidelines for Hematopoietic and Lymphoid Classifications- repost
Notice to 2024 American Board of Pathology Examination Candidates
Topic: Guidelines for Hematopoietic and Lymphoid Classifications
January 16, 2024- In response to recent inquiries, please note the Revised 4th Edition (2016) WHO classification for hematolymphoid neoplasms will be used for the 2023 Primary and Subspecialty examinations. Starting in 2024, candidates will need to be familiar with both the 2022 International Consensus Classification system and the 5th Edition of the WHO Classification.
For more information on certification exam content visit the Get Certified for information on Primary and Subspecialty exam descriptions.
This post was originally published on January 25, 2023 and again in August 2023.